ANI Pharma (ANIP) Tops Q1 EPS by 4c

ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.32, $0.04 better than the analyst estimate of $1.28. Revenue for the quarter came in at $46.5 million versus the consensus estimate of $49.93 million.

• ANI Reaffirms Guidance for the Full Year 2018

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• Avnet (AVT) Tops Q4 EPS by 61c; offers guidance
• Gibraltar Industries (ROCK) Tops Q2 EPS by 9c; reiterates guidance
• Carlyle sees improving exit conditions for "good companies"